Does SECUKINUMAB Cause Pustular psoriasis? 417 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 417 reports of Pustular psoriasis have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.3% of all adverse event reports for SECUKINUMAB.
417
Reports of Pustular psoriasis with SECUKINUMAB
0.3%
of all SECUKINUMAB reports
178
Deaths
222
Hospitalizations
How Dangerous Is Pustular psoriasis From SECUKINUMAB?
Of the 417 reports, 178 (42.7%) resulted in death, 222 (53.2%) required hospitalization, and 178 (42.7%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 417 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
USTEKINUMAB (276)
GOLIMUMAB (258)
LEFLUNOMIDE (245)
TOCILIZUMAB (233)
Which SECUKINUMAB Alternatives Have Lower Pustular psoriasis Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG